Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combined treatment with a TLR7 agonist and an HBV capsid assembly inhibitor

Combined treatment with a TLR7 agonist and an HBV capsid assembly inhibitor

US Patent 11771699 · Granted Oct 3, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds for the treatment and prophylaxis of respiratory syncytial virus disea2023
Combined treatment with a TLR7 agonist and an HBV capsid assembly inhibitor2022
Combined treatment with a TLR7 agonist and an HBV capsid assembly inhibitor2022
Process for making 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2, 7-dione2021
7-substituted sulfonimidoylpurinone compounds for the treatment of virus infecti2020
3-substituted 5-amino-6H-thiazolo[4,5-D]pyrimidine-2, 7-dione compounds for the 2020
Xanthone derivatives for the treatment of hepatitis B virus disease2020
Combination therapy of an HBV capsid assembly inhibitor and an interferon2020
7-substituted sulfonimidoylpurinone compounds and derivatives for the treatment 2019
Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus2019
3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the t2018
Imidazoles for the treatment and prophylaxis of respiratory syncytial virus infe2017